Advancements in testing for cancer in canines
Sue Ettinger, DVM, DACVIM (Oncology)—known as Dr Sue Cancer Vet—discusses recent advancements in cancer testing for canines. The highlights include 2 new low-cost, noninvasive tests.
In an interview at the Fetch dvm360® Conference in Kansas City, Sue Ettinger, DVM, DACVIM (Oncology)—known as Dr Sue Cancer Vet—discusses recent advancements in cancer testing for canines. The highlights include 2 new low-cost, noninvasive tests.
View the video for the entire discussion. The following is a partial transcript:
Sue Ettinger, DVM, DACVIM (Oncology): We used to have to do biopsies of the bladder or the prostate and now, just with a simple, free-catch urine test, we can find the cancer. And I also use the test to monitor the efficacy of my treatment as dogs are going through bladder cancer treatment or prostate cancer treatment.
Newsletter
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.
Torsemide for canine CHF: Emerging evidence and clinical benefits
June 5th 2025William Rausch, DVM, DACVIM (Cardiology), explains that torsemide offers at least equivalent efficacy to furosemide in canine CHF while significantly reducing short-term mortality/worsening events by approximately 50%.
Read More
